Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Asset Utilization Ratio (2017 - 2026)

Akebia Therapeutics has reported Asset Utilization Ratio over the past 9 years, most recently at 0.64 for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 14.83% to 0.64 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.64 through Dec 2025, down 14.83% year-over-year, with the annual reading at 0.79 for FY2025, 14.16% up from the prior year.
  • Asset Utilization Ratio was 0.64 for Q4 2025 at Akebia Therapeutics, up from 0.63 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.85 in Q1 2023 and troughed at 0.02 in Q1 2022.
  • The 5-year median for Asset Utilization Ratio is 0.66 (2022), against an average of 0.54.
  • The largest YoY upside for Asset Utilization Ratio was 20159.56% in 2022 against a maximum downside of 105.59% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.0 in 2021, then soared by 20159.56% to 0.68 in 2022, then grew by 20.02% to 0.82 in 2023, then fell by 8.29% to 0.75 in 2024, then decreased by 14.83% to 0.64 in 2025.
  • Per Business Quant, the three most recent readings for AKBA's Asset Utilization Ratio are 0.64 (Q4 2025), 0.63 (Q3 2025), and 0.62 (Q2 2025).